Almujtama Alraida Reports 30% Decline in Net Profit to SAR 7.9 Million in 2024

Almujtama Alraida Medical Co. reported a net profit of SAR 7.9 million for 2024, marking a 30% decline from SAR 11.4 million in 2023, following the release of its preliminary financial results for the period ending December 31, 2024.

Operating profit fell 44% to SAR 7.7 million in 2024, down from SAR 14 million in the previous year. Despite the profit decline, shareholders’ equity (excluding non-controlling interests) grew by 6% to SAR 138 million, compared to SAR 130 million in 2023.

Earnings per share (EPS) dropped to SAR 0.83 in 2024, down from SAR 1.2 in 2023.